PubRank

Javier Dotor

Author PubWeight™ 29.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination. J Immunol 2003 1.61
2 S-adenosylmethionine regulates cytoplasmic HuR via AMP-activated kinase. Gastroenterology 2006 1.44
3 Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol 2011 1.33
4 Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis. J Invest Dermatol 2005 1.18
5 A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury. Cytokine 2003 1.08
6 A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats. Cardiovasc Res 2008 1.07
7 A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism. Cancer Res 2008 1.05
8 In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1. J Immunol 2008 0.98
9 Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppression. Cancer Res 2010 0.97
10 Soluble factors derived from tumor mammary cell lines induce a stromal mammary adipose reversion in human and mice adipose cells. Possible role of TGF-beta1 and TNF-alpha. Breast Cancer Res Treat 2009 0.96
11 Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection. Eur J Immunol 2007 0.94
12 Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy. Int J Cancer 2009 0.92
13 Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis. Cytokine 2010 0.89
14 A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis. Cancer Res 2007 0.89
15 Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cells. Am J Respir Crit Care Med 2014 0.89
16 TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesis. Biochem Pharmacol 2008 0.88
17 Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements. Clin Cancer Res 2002 0.87
18 Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects. Cancer Immunol Immunother 2007 0.87
19 Novel pharmacologic strategies to protect the liver from ischemia-reperfusion injury. Recent Pat Cardiovasc Drug Discov 2008 0.86
20 Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides. PLoS One 2013 0.85
21 Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B. Hepatology 2012 0.84
22 Transforming growth factor-β inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptides. Invest Ophthalmol Vis Sci 2011 0.84
23 Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition. Arthritis Rheum 2013 0.84
24 GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides. PLoS One 2012 0.83
25 Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis. J Pathol 2013 0.82
26 Effect of the inhibitor peptide of the transforming growth factor beta (p144) in a new silicone pericapsular fibrotic model in pigs. Aesthetic Plast Surg 2010 0.82
27 Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer. Mol Cancer 2014 0.79
28 Blockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats. Oxid Med Cell Longev 2012 0.79
29 Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40. Antiviral Res 2007 0.78
30 A synthetic peptide from transforming growth factor-β₁ type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats. Antioxid Redox Signal 2013 0.77
31 Co-migration of colon cancer cells and CAFs induced by TGFβ₁ enhances liver metastasis. Cell Tissue Res 2015 0.76
32 Quantitative method for in vitro matrigel invasiveness measurement through image analysis software. Mol Biol Rep 2014 0.75
33 The role of Alk-1 and Alk-5 in the mechanosensing of chondrocytes. Cell Mol Biol Lett 2014 0.75